Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/ Akt signaling pathway

被引:7
作者
Yu, Qian [1 ]
Lan, Tianwei [1 ]
Ma, Zhina [1 ]
Wang, Zhanlei [1 ]
Zhang, Chunmei [2 ]
Jiang, Yichuan [1 ,3 ]
Zhao, Zhongyan [2 ,4 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Pharm, Changchun, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Crit Med, Changchun, Peoples R China
[3] Jilin Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changchun, Peoples R China
[4] Jilin Univ, China Japan Union Hosp, Dept Crit Med, 126 Xiantai St, Changchun 130033, Peoples R China
关键词
Lobaplatin (LBP); bladder cancer (BC); apoptosis; phosphoinositide 3-kinase/protein kinase B pathway (PI3K/Akt pathway); CARCINOMA; PROLIFERATION; IDELALISIB; MIGRATION; PROMOTES;
D O I
10.21037/tau-23-376
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: Lobaplatin (LBP) is a third-generation platinum-based drug that has been approved only in China for the treatment of several cancer types. Nonetheless, its efficacy in treating bladder cancer (BC) is unclear thus far. Through in vitro and in vivo experiments, this study aimed to explore whether LBP has an antitumor effect on T24 and 5637 BC cells and whether the effect is related to B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax) and regulation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway.Methods: For in vitro experiments, the cell counting kit-8 (CCK-8) method was used to determine how different concentrations of LBP affect the viability of two types of BC cells. A wound healing assay was used to test the inhibitory effect of LBP on the migration of the two cell lines. Annexin V-fluorescein isothiocyanate isomer I (V-FITC)/propidium iodide (PI) staining was used to detect changes in cell apoptosis before and after LBP treatment, and Western blotting was used to detect the expression of apoptosis-related proteins and PI3K/Akt pathway proteins. For in vivo experiments, a cell-derived xenograft (CDX) model was employed, and the weight of nude mice and the tumor size were measured. Immunohistochemistry was used to detect the effect of LBP on the expression of apoptosis-related proteins in tumor xenografts.Results: In vitro, LBP reduced proliferation (P<0.05), inhibited migration (P<0.05), and induced apoptosis in T24 (31.25%& PLUSMN;1.20%, P<0.01) and 5637 (14.3%& PLUSMN;2.24%, P<0.05) BC cells, in a dose-dependent manner (P<0.05); increased the expression of proapoptotic proteins, including Bax, caspase-3 and cleaved caspase-3 (P<0.05); and suppressed the expression of antiapoptotic proteins, including Bcl-2, PI3K, Akt and phosphorylated Akt (p-Akt). The in vivo experiment confirmed that LBP can reduce the size of subcutaneous tumors in nude mice (P<0.05), increase the expression levels of Bax and cleaved caspase-3 and lower the expression of Bcl-2 (P<0.05) in bladder tumor tissue.Conclusions: The results obtained from both experiments suggest that LBP can inhibit the proliferation of T24 and 5637 BC cells, which might be credited to its effects in regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt pathway.
引用
收藏
页码:1296 / 1307
页数:12
相关论文
共 43 条
[1]  
[Anonymous], 2003, Drugs R D, V4, P369
[2]   Molecular aspects of tumor cell migration and invasion [J].
Bozzuto, Giuseppina ;
Ruggieri, Paola ;
Molinari, Agnese .
ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2010, 46 (01) :66-80
[3]   Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX [J].
Cao, Hongwen ;
Feng, Yigeng ;
Chen, Lei ;
Yu, Chao .
DOSE-RESPONSE, 2019, 17 (02)
[4]  
Chen HX, 2016, FRONT BIOSCI-LANDMRK, V21, P1084
[5]   Lobaplatin Induces Pyroptosis in Cervical Cancer Cells via the Caspase-3/GSDME Pathway [J].
Chen, Jie ;
Ge, Lili ;
Shi, Xiaoyan ;
Liu, Juan ;
Ruan, Hongjie ;
Heng, Dou ;
Ye, Chunping .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (11) :2091-2097
[6]   Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma [J].
Chen, Zide ;
Xu, Gang ;
Wu, Dong ;
Wu, Shihai ;
Gong, Long ;
Li, Zihuang ;
Luo, Guanghong ;
Hu, Jian ;
Chen, Jian ;
Huang, Xiaoting ;
Chen, Chengcong ;
Jiang, Zhenyou ;
Li, Xianming .
BIOCHEMICAL PHARMACOLOGY, 2020, 177
[7]   Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics [J].
Costa, Ceu ;
Pereira, Sofia ;
Lima, Luis ;
Peixoto, Andreia ;
Fernandes, Elisabete ;
Neves, Diogo ;
Neves, Manuel ;
Gaiteiro, Cristiana ;
Tavares, Ana ;
Gil da Costa, Rui M. ;
Cruz, Ricardo ;
Amaro, Teresina ;
Oliveira, Paula A. ;
Ferreira, Jose Alexandre ;
Santos, Lucio L. .
PLOS ONE, 2015, 10 (11)
[8]   Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio [J].
Du, Leiwen ;
Fei, Zhenghua ;
Song, Shuichuan ;
Wei, Nan .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 :447-452
[9]   Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells [J].
Duan, Fengsen ;
Mei, Chunlei ;
Yang, Luhao ;
Zheng, Junyan ;
Lu, Huiai ;
Xia, Yanzhi ;
Hsu, Stacy ;
Liang, Huageng ;
Hong, Ling .
SCIENTIFIC REPORTS, 2020, 10 (01)
[10]   PI3K Inhibitors in Breast Cancer Therapy [J].
Ellis, Haley ;
Ma, Cynthia X. .
CURRENT ONCOLOGY REPORTS, 2019, 21 (12)